Indeed, TNFα is successfully used to treat in transit melanoma metastases and its presence within tumors has been shown to be induced by and synergize with ICIs in melanoma patients (39, 40), while its systemic blockage is associated with a reduced survival (41). This evidence concerns the gene TNF and melanoma.